Dr. Hillary Alison Glick, MD

Dr. Glick practices at St Andrews Campus of Lincolnhealth in Boothbay Harbor, Maine.

Dr. Glick's NPI, 1801241989, was assigned on April 26, 2016. Dr. Glick holds Maine license MD25748.

Dr. Glick's primary practice is St Andrews Campus of Lincolnhealth, at 6 St Andrews Ln, Boothbay Harbor, ME 04538 in Lincoln County. The practice phone is (207) 563-1234.

Dr. Glick's primary practice is St Andrews Campus of Lincolnhealth in Boothbay Harbor, Maine. Dr. Glick is also affiliated with MaineHealth Maine Medical Center. The medical group on file is MaineHealth Primary Care - Family Medicine - Portland. Dmand AI also links Dr. Glick to 4 more hospitals, 2 group practices and clinics, 2 medical groups, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Glick practices, 9 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Glick's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Glick's licenses on file in 2 states: Maine and New Hampshire.

CMS data shows 141 Medicare services from Dr. Glick across 2 procedure codes in 2024, all of them office visits, for 73 Medicare patients. Medicare paid $12,157 for them. Every service was in an office.

CMS counts 73 Medicare patients who saw Dr. Glick in 2024. The largest group is 75 to 84, with 29 patients. 75% of them have high blood pressure, and 62% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Glick's median patient age at 75, with 54% women.

In 2024, Dr. Glick wrote 792 Medicare Part D claims for 180 patients. 83% of them were for generic drugs. CMS names the drug for 560 of them, across 24 drugs with 11 or more claims each, at $932,074 in total drug cost. In 2023, CMS named 443 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Glick for performance year 2024, reported through an alternative payment model (APM). Dr. Glick accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Glick from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $215.